Likewise, polysialic acid-based nanoparticles conjugated to cCpE then loaded with doxorubicin were shown to specifically target claudin-4-expressing pancreatic cancer and suppress tumor growth while exerting low toxicity to normal tissues [102]. This evidence concerns the gene CLDN4 and pancreatic neoplasm.